This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Yerjiang Sulitang: Innovator in Crystalline Lens Diagnosis and Treatment
Introduction
Yerjiang Sulitang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of ophthalmology, particularly in the diagnosis and treatment of crystalline lens lesions, such as cataracts. His innovative approach utilizes genetic analysis to improve patient outcomes.
Latest Patents
Yerjiang Sulitang holds a patent for a method of diagnosing and treating lesions of the crystalline lens using the human CRYGS gene and its coding product. This patent outlines a method for detecting variations in the crygs gene, transcript, and/or protein in individuals. The presence of such variations indicates a higher likelihood of cataract development compared to normal individuals. Additionally, the patent includes a pharmaceutical composition for treating these lesions.
Career Highlights
Yerjiang Sulitang is affiliated with the Chinese Academy of Sciences, where he conducts research and develops innovative solutions in the field of eye health. His work has garnered attention for its potential to revolutionize cataract diagnosis and treatment.
Collaborations
He has collaborated with notable colleagues, including Xiangyin Kong and Lei Bu, to advance research in this critical area of healthcare.
Conclusion
Yerjiang Sulitang's contributions to the diagnosis and treatment of crystalline lens lesions highlight the importance of innovation in medical science. His work not only enhances our understanding of cataracts but also paves the way for improved therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile